Short Interest in Centogene (NASDAQ:CNTG) Decreases By 47.9%

Centogene (NASDAQ:CNTG) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 6,200 shares, a decline of 47.9% from the March 31st total of 11,900 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 57,700 shares, the short-interest ratio is presently 0.1 days.

Centogene Stock Performance

Shares of CNTG stock traded up $0.01 during midday trading on Friday, hitting $0.49. 6,902 shares of the company were exchanged, compared to its average volume of 49,076. The firm’s 50 day moving average price is $0.67 and its two-hundred day moving average price is $0.99. Centogene has a 52 week low of $0.43 and a 52 week high of $1.98.

About Centogene

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.